[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

February 2019 - January 1920

Decade

Year

Issue

March 2019, Vol 155, No. 3, Pages 269-404

In This Issue of JAMA Dermatology

Highlights

Abstract Full Text
free access
JAMA Dermatol. 2019;155(3):269. doi:10.1001/jamadermatol.2018.3503
Editorial

Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies—Taming T REX

Abstract Full Text
JAMA Dermatol. 2019;155(3):283-284. doi:10.1001/jamadermatol.2018.4836

Gender Equity in Clinical Dermatology—Reason for Optimism

Abstract Full Text
JAMA Dermatol. 2019;155(3):284-286. doi:10.1001/jamadermatol.2018.5283

Dermatologists and Antibiotics—Reflecting on Our Habits, the Evidence, and Next Steps

Abstract Full Text
JAMA Dermatol. 2019;155(3):286-287. doi:10.1001/jamadermatol.2018.4877
Original Investigation

Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016

Abstract Full Text
has audio
JAMA Dermatol. 2019;155(3):290-297. doi:10.1001/jamadermatol.2018.4944

This repeated cross-sectional analysis of antibiotic prescribing by dermatologists characterizes the use of antibiotics in dermatology, including changes over time, from 2008 to 2016.

Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England

Abstract Full Text
JAMA Dermatol. 2019;155(3):298-306. doi:10.1001/jamadermatol.2018.4219

This population-based study assesses the national incidence of cutaneous and metastatic cutaneous squamous cell carcinoma in England from 2013 through 2015.

Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant

Abstract Full Text
JAMA Dermatol. 2019;155(3):307-314. doi:10.1001/jamadermatol.2018.4983

This secondary analysis of a large cohort study analyzes the HLA antigen mismatches and molecular mechanisms that affect the incidence of posttransplant skin cancer among solid-organ transplant recipients.

Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology

Abstract Full Text
JAMA Dermatol. 2019;155(3):315-320. doi:10.1001/jamadermatol.2018.5052

This cross-sectional study examines the 2 clinical compendia used for Medicare part D to evaluate the inclusion of evidence-based off-label uses of treatments for dermatologic diseases.

Comparison of Running Cutaneous Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis of the Face and Neck: A Randomized Clinical Trial

Abstract Full Text
JAMA Dermatol. 2019;155(3):321-326. doi:10.1001/jamadermatol.2018.5057

This randomized clinical trial uses a split-wound/split-scar model to compare the outcomes and wound cosmesis achieved with running cutaneous sutures spaced 2 vs 5 mm apart.

Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis

Abstract Full Text
JAMA Dermatol. 2019;155(3):327-334. doi:10.1001/jamadermatol.2018.5194

This cohort study compares the effectiveness and adverse effects of methotrexate in Chinese patients with psoriasis with and without psoriatic arthritis.

Comparison of Narrowband UV-B With Psoralen–UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Dermatol. 2019;155(3):335-341. doi:10.1001/jamadermatol.2018.5204

This systematic review and meta-analysis compares response and adverse effects of psoralen–UV-A with narrowband UV-B phototherapy in patients with early-stage mycosis fungoides.

Brief Report

Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation

Abstract Full Text
open access
JAMA Dermatol. 2019;155(3):342-346. doi:10.1001/jamadermatol.2018.5077

This case series evaluates the clinical response to the Janus kinase inhibitor baricitinib in 3 individuals with familial chilblain lupus and assesses the effect of cold on fibroblasts.

Evaluation of the Response of Unresectable Primary Cutaneous Melanoma to Immunotherapy Visualized With Reflectance Confocal Microscopy: A Report of 2 Cases

Abstract Full Text
JAMA Dermatol. 2019;155(3):347-352. doi:10.1001/jamadermatol.2018.3688

This case report study describes 2 patients with locally advanced primary melanomas and the use of reflectance confocal microscopy for imaging of cutaneous involvement and disease monitoring.

Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias

Abstract Full Text
JAMA Dermatol. 2019;155(3):353-357. doi:10.1001/jamadermatol.2018.4216

This cohort study assesses a possible association between health care screening practices and skin cancer risk using data from the Nurses’ Health Study and Health Professionals Follow-up Study.

Review

Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review

Abstract Full Text
has active quiz
JAMA Dermatol. 2019;155(3):361-369. doi:10.1001/jamadermatol.2018.4940

This systematic review evaluates the use of imatinib to treat locally advanced or metastatic dermatofibrosarcoma protuberans.

Images in Dermatology

Oral Kaposi Sarcoma

Abstract Full Text
JAMA Dermatol. 2019;155(3):370. doi:10.1001/jamadermatol.2018.4079

This case report describes a man in his 50s with a hemorrhagic nodule on his left lower cheek that developed at the site of an abrasion from a motor vehicle crash.

Systemic Amyloidosis

Abstract Full Text
JAMA Dermatol. 2019;155(3):371. doi:10.1001/jamadermatol.2018.4413

This case report describes a patient with systemic amyloidosis.

JAMA Dermatology Clinicopathological Challenge

Recurrent Bullous Eruption in a Young Woman

Abstract Full Text
JAMA Dermatol. 2019;155(3):373-374. doi:10.1001/jamadermatol.2018.4006

A woman in her 20s had round erythematous plaques with central pallor and blisters at the periphery on both forearms. What is your diagnosis?

Arthropathy and Cutaneous Eruption in a Patient With Cystic Fibrosis

Abstract Full Text
JAMA Dermatol. 2019;155(3):375-376. doi:10.1001/jamadermatol.2018.5018

A girl with cystic fibrosis presented with a 2-year history of a relapsing-remitting, evanescent, salmon-pink maculopapular cutaneous eruption that was associated with joint pain. What is your diagnosis?

Flexural Hyperpigmentation With Reticulation in an Adolescent Girl

Abstract Full Text
JAMA Dermatol. 2019;155(3):377-378. doi:10.1001/jamadermatol.2018.5033

An adolescent girl with polycystic ovarian syndrome presented with hyperpigmented skin lesions on her neck, upper limbs, and trunk, which had begun 6 months previously as recurrent pruritic erythematous papules that subsided leaving brownish-bluish black hyperpigmentation. What is your diagnosis?

Research Letter

Supplementing Dermatology Physician Resident Education in Vasculitis and Autoimmune Connective Tissue Disease: A Prospective Study of an Online Curriculum

Abstract Full Text
JAMA Dermatol. 2019;155(3):381-383. doi:10.1001/jamadermatol.2018.4837

This prospective study examines the influence of an online curriculum in residents’ knowledge of cutaneous manifestations of vasculitis and autoimmune connective tissue diseases.

Trends in Gender of Speakers at the American Academy of Dermatology Annual Meeting, 2010-2018

Abstract Full Text
JAMA Dermatol. 2019;155(3):383-384. doi:10.1001/jamadermatol.2018.5466

This retrospective review of American Academy of Dermatology Annual Meeting data for even years between 2010 and 2018 was performed to identify the number of female speakers and associated presentation times.

Assessment of Percentage of Women in the Dermatology Workforce Presenting at American Academy of Dermatology Annual Meetings, 1992-2017

Abstract Full Text
JAMA Dermatol. 2019;155(3):384-386. doi:10.1001/jamadermatol.2018.5481

This study assesses the percentage of female speakers at American Academy of Dermatology conferences from 1992 through 2017 and compares it with the overall percentages of board-certified female dermatologists.

Representation of Women Among Physician Authors of Perspective-Type Articles in High-Impact Dermatology Journals

Abstract Full Text
JAMA Dermatol. 2019;155(3):386-388. doi:10.1001/jamadermatol.2018.5517

This cross-sectional, descriptive study analyzes the number of women among physician first authors of articles published in the Journal of the American Academy of Dermatology and JAMA Dermatology across a 5-year period.

Observation

A Case of Pansclerotic Morphea Treated With Tocilizumab

Abstract Full Text
JAMA Dermatol. 2019;155(3):388-389. doi:10.1001/jamadermatol.2018.5040

This case report describes a patient with pansclerotic morphea treated with tocilizumab.

Flexural Eruption Associated With Arsenic Trioxide Therapy in a Patient With Acute Promyelocytic Leukemia

Abstract Full Text
JAMA Dermatol. 2019;155(3):389-391. doi:10.1001/jamadermatol.2018.5258

This case report describes a patient with acute promyelocytic leukemia who developed a flexural eruption associated with arsenic trioxide therapy.

Decrease of Anti-DSG3, but Not Anti-DSG1 Antibody, After Cessation of Sitagliptin Treatment in a Patient With Pemphigus Vulgaris

Abstract Full Text
JAMA Dermatol. 2019;155(3):391-393. doi:10.1001/jamadermatol.2018.5379

This case report describes the occurrence of a decrease of anti-DSG3, but not anti-DSG1, after cessation of sitagliptin treatment in a patient with pemphigus vulgaris.

Comment & Response

Further Consideration of the Pigmented Lesion Assay

Abstract Full Text
JAMA Dermatol. 2019;155(3):393. doi:10.1001/jamadermatol.2018.5478

Further Consideration of the Pigmented Lesion Assay—Reply

Abstract Full Text
JAMA Dermatol. 2019;155(3):393-394. doi:10.1001/jamadermatol.2018.4377

Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma

Abstract Full Text
JAMA Dermatol. 2019;155(3):394-395. doi:10.1001/jamadermatol.2018.3719

Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma

Abstract Full Text
JAMA Dermatol. 2019;155(3):395. doi:10.1001/jamadermatol.2018.4572

Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma

Abstract Full Text
JAMA Dermatol. 2019;155(3):395-396. doi:10.1001/jamadermatol.2018.5661

Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma—Reply

Abstract Full Text
JAMA Dermatol. 2019;155(3):396-397. doi:10.1001/jamadermatol.2018.5664
Correction

Data Errors in Tables 1 and 2

Abstract Full Text
free access
JAMA Dermatol. 2019;155(3):397. doi:10.1001/jamadermatol.2019.0226
JAMA Dermatology Patient Page

Pityriasis Rubra Pilaris

Abstract Full Text
free access
JAMA Dermatol. 2019;155(3):404. doi:10.1001/jamadermatol.2018.5030

This Patient Page describes pityriasis rubra pilaris

JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2019;155(3):272. doi:10.1001/jamadermatol.2018.3504
×